Rolf J. Verheul

1.1k total citations
22 papers, 832 citations indexed

About

Rolf J. Verheul is a scholar working on Molecular Biology, Pharmaceutical Science and Epidemiology. According to data from OpenAlex, Rolf J. Verheul has authored 22 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmaceutical Science and 6 papers in Epidemiology. Recurrent topics in Rolf J. Verheul's work include Advanced Drug Delivery Systems (6 papers), Cerebrospinal fluid and hydrocephalus (3 papers) and Immunotherapy and Immune Responses (3 papers). Rolf J. Verheul is often cited by papers focused on Advanced Drug Delivery Systems (6 papers), Cerebrospinal fluid and hydrocephalus (3 papers) and Immunotherapy and Immune Responses (3 papers). Rolf J. Verheul collaborates with scholars based in Netherlands, United States and Germany. Rolf J. Verheul's co-authors include Wim E. Hennink, Wim Jiskoot, Bram Slütter, Steffen van der Wal, Elly van Riet, Maryam Amidi, Suzanne M. Bal, Joke A. Bouwstra, Peter C. Soema and Zhi Ding and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Biomacromolecules.

In The Last Decade

Rolf J. Verheul

21 papers receiving 821 citations

Peers

Countries citing papers authored by Rolf J. Verheul

Since Specialization

Citations

This map shows the geographic impact of Rolf J. Verheul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf J. Verheul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf J. Verheul more than expected).

Fields of papers citing papers by Rolf J. Verheul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf J. Verheul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf J. Verheul. The network helps show where Rolf J. Verheul may publish in the future.

Co-authorship network of co-authors of Rolf J. Verheul

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf J. Verheul. A scholar is included among the top collaborators of Rolf J. Verheul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf J. Verheul. Rolf J. Verheul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical value of S100B in detecting intracranial injury in elderly patients with mild traumatic brain injury 2024 ·Injury ·(unknown), (unknown), Rolf J. Verheul, Joukje van der Naalt, Crispijn L. van den Brand, Korné Jellema	7
2	The impact of prehospital blood sampling on the emergency department process of patients with chest pain: a pragmatic non-randomized controlled trial 2023 ·World Journal of Emergency Medicine ·(unknown), M Linden, Rolf J. Verheul, (unknown), (unknown), Naomi van der Linden	1
3	Biomarker S100B in plasma a screening tool for mild traumatic brain injury in an emergency department 2022 ·Brain Injury ·(unknown), (unknown), Kelly Foks, Rolf J. Verheul, (unknown), Crispijn L. van den Brand, Korné Jellema	11
4	Diagnostic Accuracy of Clinical Signs and Biochemical Parameters for External Ventricular CSF Catheter-Associated Infection 2022 ·Neurology Clinical Practice ·(unknown), Rolf J. Verheul, Gabriëlle Ponjee, Rishi Nandoe Tewarie, Marcella C.A. Müller, Diederik van de Beek, Matthijs C. Brouwer, Korné Jellema	2
5	Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey 2021 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Wilhelmine P.H.G. Verboeket‐van de Venne, Carine J.M. Doggen, (unknown), Lale Erdem‐Eraslan, Albert J. de Graaf, Johannes G. Krabbe, (unknown), Wytze P. Oosterhuis, Yolanda B. de Rijke, Heleen van der Sijs, Andrei N. Tintu, Rolf J. Verheul, (unknown), Ron Kusters	3
6	Real-time monitoring of drug laboratory test interactions: a proof of concept 2021 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Wilhelmine P.H.G. Verboeket‐van de Venne, Carine J.M. Doggen, Lale Erdem‐Eraslan, Albert J. de Graaf, Johannes G. Krabbe, (unknown), Wytze P. Oosterhuis, Yolanda B. de Rijke, Heleen van der Sijs, Andrei N. Tintu, Rolf J. Verheul, (unknown), Ron Kusters	2
7	Diagnostic error as a result of drug-laboratory test interactions 2019 ·Diagnosis ·(unknown), Wilhelmine P.H.G. Verboeket‐van de Venne, Lale Erdem‐Eraslan, Albert J. de Graaf, Annemarieke E. Loot, (unknown), Wytze P. Oosterhuis, Martin P. Schuijt, Heleen van der Sijs, Rolf J. Verheul, (unknown), Ron Kusters, (unknown)	5
8	Cytomegalovirus infection with pulmonary embolism, splenic vein thrombosis and monoclonal gammopathy of undetermined significance: a case and systematic review 2019 ·BMJ Case Reports ·Esther de Rooij, Rolf J. Verheul, (unknown), Ype de Jong	0
9	Impact of interactions between drugs and laboratory test results on diagnostic test interpretation – a systematic review 2018 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Wilhelmine P.H.G. Verboeket‐van de Venne, Lale Erdem‐Eraslan, Albert J. de Graaf, Annemarieke E. Loot, (unknown), Wytze P. Oosterhuis, Martin P. Schuijt, Heleen van der Sijs, Rolf J. Verheul, (unknown), Ron Kusters, (unknown), (unknown)	12
10	The value of CT angiography in patients with acute severe headache 2014 ·Acta Neurologica Scandinavica ·(unknown), Ido R. van den Wijngaard, Rolf J. Verheul, Geert J. Lycklama à Nijeholt, Marieke J.H. Wermer, Ale Algra, Korné Jellema	11
11	A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine 2011 ·European Journal of Pharmaceutical Sciences ·Rolf J. Verheul, Niels Hagenaars, (unknown), Ethlinn V.B. van Gaal, (unknown), Sven C. M. Bruijns, Enrico Mastrobattista, Bram Slütter, Ivo Que, Jacco Heldens, Han van den Bosch, Harrie L. Glansbeek, Wim E. Hennink, Wim Jiskoot	11
12	Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice 2011 ·European Journal of Pharmaceutical Sciences ·Suzanne M. Bal, Bram Slütter, Rolf J. Verheul, Joke A. Bouwstra, Wim Jiskoot	78
13	Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination 2011 ·Journal of Controlled Release ·Rolf J. Verheul, Bram Slütter, Suzanne M. Bal, Joke A. Bouwstra, Wim Jiskoot, Wim E. Hennink	83
14	Gene Silencing Activity of siRNA Polyplexes Based on Thiolated N,N,N-Trimethylated Chitosan 2010 ·Bioconjugate Chemistry ·Amir K. Varkouhi, Rolf J. Verheul, Raymond M. Schiffelers, Twan Lammers, Gert Storm, Wim E. Hennink	47
15	Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen 2010 ·Journal of Controlled Release ·Bram Slütter, Peter C. Soema, Zhi Ding, Rolf J. Verheul, Wim E. Hennink, Wim Jiskoot	125
16	Tailorable Thiolated Trimethyl Chitosans for Covalently Stabilized Nanoparticles 2010 ·Biomacromolecules ·Rolf J. Verheul, Steffen van der Wal, Wim E. Hennink	43
17	Influence of the degree of acetylation on the enzymatic degradation and in vitro biological properties of trimethylated chitosans 2009 ·Biomaterials ·Rolf J. Verheul, Maryam Amidi, Mies J. van Steenbergen, Elly van Riet, Wim Jiskoot, Wim E. Hennink	86
18	Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine 2009 ·Journal of Controlled Release ·Niels Hagenaars, Rolf J. Verheul, (unknown), (unknown), Enrico Mastrobattista, Harrie L. Glansbeek, Jacco Heldens, Han van den Bosch, Wim E. Hennink, Wim Jiskoot	49
19	Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration 2009 ·Pharmaceutical Research ·Niels Hagenaars, Enrico Mastrobattista, Rolf J. Verheul, (unknown), Harrie L. Glansbeek, Jacco Heldens, Han van den Bosch, Wim Jiskoot	47
20	Synthesis, characterization and in vitro biological properties of O-methyl free N,N,N-trimethylated chitosan 2008 ·Biomaterials ·Rolf J. Verheul, Maryam Amidi, Steffen van der Wal, Elly van Riet, Wim Jiskoot, Wim E. Hennink	179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact